Live from the NIH registry
Studies recruiting near Austin right now
Top 25 of 723 recruiting studies, sorted by proximity — each links to its official registry page
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Dell Children's Medical Center of Central Texas — Austin, Texas (2.4 mi)
· Sponsor: National Cancer Institute (NCI)
Open Label, Controlled, Post Marketing, Registry Study of Ribociclib (Ribo) Treatment Adherence and Patient Reported Outcomes in Participants Using ReX Technology Platform
Any Solid Oral Medication
N/A
Interventional 200 participants sought
Texas Oncology — Austin, Texas (2.4 mi)
· Sponsor: Dosentrx Ltd.
A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine
Migraine
Phase 2
Interventional 488 participants sought
FutureSearch Trials — Austin, Texas (2.4 mi)
· Sponsor: AbbVie
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
N/A
Interventional 400 participants sought
Texas Diabetes & Endocrinology — Austin, Texas (2.4 mi)
· Sponsor: Medtronic MiniMed, Inc.
PAS-004 in Patients With Advanced Solid Tumors
RAS Mutation, NF1 Mutation
Phase 1
Interventional 48 participants sought
NEXT Oncology — Austin, Texas (2.4 mi)
· Sponsor: Pasithea Therapeutics Corp.
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
Texas Oncology Central/South — Austin, Texas (2.4 mi)
· Sponsor: Relay Therapeutics, Inc.
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Carcinoma, Transitional Cell, Urinary Bladder Neoplasms
Phase 3
Interventional 450 participants sought
USO-Texas Oncology-Central/South Texas — Austin, Texas (2.4 mi)
· Sponsor: Eli Lilly and Company
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
Narcolepsy Type 1
Phase 3
Interventional 150 participants sought
Alkermes Investigational Site — Austin, Texas (2.4 mi)
· Sponsor: Alkermes, Inc.
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Neovascular Age-related Macular Degeneration
Phase 4
Interventional 188 participants sought
Austin Retina Associates — Austin, Texas (2.4 mi)
· Sponsor: Genentech, Inc.
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
Heart Failure
Phase 3
Interventional 1,500 participants sought
CON-10015 Austin, TX Investigational Site — Austin, Texas (2.4 mi)
· Sponsor: Colorado Prevention Center
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
Chronic Migraine
Phase 3
Interventional 420 participants sought
UT Health Austin at Dell Childrens Neurology Clinic /ID# 270577 — Austin, Texas (2.4 mi)
· Sponsor: AbbVie
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — Austin, Texas (2.4 mi)
· Sponsor: AstraZeneca
Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections
Pulmonary Invasive Fungal Infections, Pulmonary Invasive Aspergillosis
N/A
Observational 400 participants sought
Ascension Seton Medical Center — Austin, Texas (2.4 mi)
· Sponsor: Arkansas Children's Hospital Research Institute
Integrated Tele-Behavioral Activation and Fall Prevention for Low-income Homebound Seniors With Depression
Depression, Unipolar, Fall
N/A
Interventional 320 participants sought
University of Texas at Austin — Austin, Texas (2.4 mi)
· Sponsor: University of Texas at Austin
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
Neuroblastoma
Phase 2
Interventional 93 participants sought
Dell Children's Blood and Cancer Center — Austin, Texas (2.4 mi)
· Sponsor: Giselle Sholler
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Percutaneous Coronary Intervention, Peripheral Endovascular Intervention
Phase 4
Interventional 6,000 participants sought
Austin Heart — Austin, Texas (2.4 mi)
· Sponsor: Duke University
Multi-Center Registry for Peripheral Arterial Disease Interventions and Outcomes
Peripheral Arterial Disease
N/A
Observational 14,000 participants sought
Seton Heart Institute/ UT Austin — Austin, Texas (2.4 mi)
· Sponsor: Baylor Research Institute
Safety and Effectiveness of Pulmonary Vein isOLation And posterioR Wall Ablation wIth pulSed Field Energy in Patients With Paroxysmal and Persistent AF
Atrial Fibrillation
N/A
Interventional 442 participants sought
Texas Cardiac Arrhythmia Institute/Research Foundation — Austin, Texas (2.4 mi)
· Sponsor: Massachusetts General Hospital
Mothers and CareGivers Investing in Children Study 2.0
Childhood Obesity Prevention, Parenting Behavior
N/A
Interventional 266 participants sought
Sarah M. & Charles E. Seay Building — Austin, Texas (2.4 mi)
· Sponsor: University of Texas at Austin
A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System
Atrial Fibrillation
N/A
Interventional 276 participants sought
Texas Cardiac Arrhythmia Research Foundation — Austin, Texas (2.4 mi)
· Sponsor: Biosense Webster, Inc.
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
Cancer, Tumor, Solid
Phase 1, Phase 2
Interventional 168 participants sought
NEXT Austin — Austin, Texas (2.4 mi)
· Sponsor: OncoResponse, Inc.
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
Asthma
Phase 3
Interventional 440 participants sought
Research Site — Austin, Texas (2.4 mi)
· Sponsor: AstraZeneca
Evaluation of the FARAFLEX Mapping and Pulsed Field Ablation System in Subjects With Atrial Fibrillation
Paroxysmal Atrial Fibrillation (PAF), Persistent Atrial Fibrillation
N/A
Interventional 571 participants sought
Texas Cardiac Arrhythmia Research — Austin, Texas (2.4 mi)
· Sponsor: Boston Scientific Corporation
[18F]PI-2620 Phase 3 Histopathological Study
Alzheimer Disease
Phase 3
Interventional 200 participants sought
Be Well Clinical Studies — Round Rock, Texas (15.0 mi)
· Sponsor: Lantheus Biosciences Ltd.
Barrigel® PPRT (Post-Prostatectomy Radiation Therapy) Trial
Prostate Cancer
N/A
Interventional 84 participants sought
Urology Austin — Austin, Texas (2.4 mi)
· Sponsor: Palette Life Sciences, Inc.